Aspire Biopharma Holdings (ASBP) Live Share Price, Invest From India

Aspire Biopharma Holdings Stock Performance

as on November 7, 2026 at 2:16 pm IST

Day's Low
Day's High
$6.90
Day's Price Range
$7.99
$8.09
14.71%
Downside
-1.24%
Upside
52 Week's Low
52 Week's High
$3.31
52-Week Price Range
$372.00
$8.09
59.10%
Downside
4498.27%
Upside

Aspire Biopharma Holdings share price movements today

Previous Close: $6.76
Open: $6.90
Volume: 138.1K
Market Cap: $9.5M
Day's Low - High: $6.90 - $7.99
52 Week Low - High: $3.31 - $372.00

Aspire Biopharma Holdings Historical Returns

1 Month Return: -6.26 %
3 Month Return: + 4.66 %
1 Year Return: -97.19 %
3 Year Return: 0 %
5 Year Return: 0 %

Aspire Biopharma Holdings Stock Fundamentals & Key Indicators

Check Aspire Biopharma Holdings market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.5M

EPS (TTM)

-8.02

Dividend Yield

0.00%

PE Ratio (TTM)

-1.01

Industry PE ratio

12.11

PEG Ratio

-0.01

Return On Equity TTM

1993.26%

Aspire Biopharma Holdings vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aspire Biopharma Holdings with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Aspire Biopharma Holdings	NA	$9.5M	NA	-1.01	18.35%	0.00%
Knorr-Bremse	NA	$17.0B	NA	24.60	23.10%	2.08%
O'Reilly Auto	StrongBuy	$73.6B	111.31%	27.41	51.79%	0.00%
AutoZone	StrongBuy	$53.3B	76.92%	20.60	52.34%	0.00%
Magna International	Neutral	$16.9B	-25.66%	20.00	11.25%	3.14%

See all

Stock Returns calculator for Aspire Biopharma Holdings Stock including INR - Dollar returns

The Aspire Biopharma Holdings stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Aspire Biopharma Holdings investment value today

Current value as on today

₹2,974

Returns

-₹97,026

(-97.03%)

Returns from Aspire Biopharma Holdings Stock

-₹97,192 (-97.19%)

Dollar Impact

₹166 (+0.17%)

Indian Investors' Interest in Aspire Biopharma Holdings Stock

Search interest for Aspire Biopharma Holdings Stock has decreased by -48% in the last 30 days, reflecting a downward trend in search activity.

Time period: October 9, 2026 to November 8, 2026

Change:-48% versus previous 30 day period

Aspire Biopharma Holdings Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	0	0	0	0
Gross Profit	-	-	-	-	-	-	0	0	0	0
Operating Income	-	0	0	0	-15	0	-1	-1	-1	-2
EBITDA	-2	1	0	0	-15	-1	1	4	0	-2
Interest Expense	0	0	-	0	0	0	1	6	1	-
Depreciation	-	-	-	-	-	-	2	5	1	-
Income Before Tax	-2	0	0	0	-15	-1	-1	-4	-3	-1
Income Tax Expense	-	-	0	-	-	-	-	-	-	-
Net Income	-2	0	0	0	-15	-1	-1	-4	-3	-1
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	45.54%	-23.47%	20.28%	19.47%

Aspire Biopharma Holdings Annual Profit & Loss

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	0
Gross Profit	-	-	-	-	0
Operating Income	0	0	-1	-1	-19
EBITDA	0	0	5	-1	-11
Interest Expense	-	-	0	0	8
Depreciation	0	-	1	-	8
Income Before Tax	0	3	4	-1	-24
Income Tax Expense	-	-	-	0	-
Net Income	0	3	4	-1	-24
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-1.87%

Aspire Biopharma Holdings Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-2	0	0	0	-15	-1	-1	-4	-3	-1
Operating Cash Flow	-2	0	-533	0	-1	-1	-1	0	-3	-2
Investing Cash Flow	-	13	38	-	-	-	-	-	-	-
Financing Cash Flow	2	-13	492	0	3	-	2	0	7	8
Change in Cash	-	-27	-3	0	1	-1	1	0	4	6

Aspire Biopharma Holdings Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	0	0	4	-1	-24
Operating Cash Flow	0	0	0	0	-4
Investing Cash Flow	-	-4	284	-	-
Financing Cash Flow	0	4	-284	0	5
Change in Cash	-	0	0	0	1

Global Institutional Holdings in Aspire Biopharma Holdings

Check out the Institutions with significant holdings in Aspire Biopharma Holdings.

Funds	Holdings
Vanguard	1.34%
Fidelity Concord Street Trust	1.00%
Ken Fisher	0.71%
VANGUARD INDEX FUNDS	0.02%

Insights on Aspire Biopharma Holdings

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 6 months, ASBP stock has moved up by 45.8%
NO EFFECT
Against Peers
In the last 1 year, Magna International has given 24.0% return, outperforming this stock by 121.2%
NO EFFECT
Against Peers
In the last 3 years, Knorr-Bremse AG American Depositary Receipts - Unsponsored Germany Federal Republic has given 19.5% return, outperforming this stock by 45.3%

About Aspire Biopharma Holdings

Aspire Biopharma Holdings, Inc. is an emerging pharmaceutical enterprise dedicated to pioneering and commercializing innovative sublingual drug delivery systems within the United States. Its flagship product, Instaprin, is an advanced sublingual aspirin formulation known for being soluble, pH neutral, and rapidly absorbed, making it effective for both cardiovascular emergencies and general pain management. The company is diligently developing a diverse pipeline of orally dissolving formulations. This includes a melatonin-based sleep aid, essential vitamins (D, E, and K), testosterone, and semaglutide. Furthermore, Aspire Biopharma is extending its sublingual development efforts to various therapeutic areas, such as anti-nausea treatments, antipsychotic medications, erectile dysfunction drugs, and seizure control therapies, among others. They are also exploring caffeine products, including a formulation for a single-dose sublingual pre-workout supplement. Established in 2021, the firm's main operational base is situated in Estero, Florida.

Organisation	Aspire Biopharma Holdings
Headquarters	23150 Fashion Drive, Estero, FL, 33928, US
Industry	Medical - Pharmaceuticals
CEO	Kraig T. Higginson

Key Management of Aspire Biopharma Holdings

Name	Title
Mr. Kraig T. Higginson	Interim CEO, President & Executive Chairman of the Board
Mr. Ernest J. Scheidemann Jr.	Chief Financial Officer
Mr. Stephen E. Quesenberry	General Counsel & Corporate Secretary

FAQs

What is Aspire Biopharma Holdings share price today?

Aspire Biopharma Holdings share price today is $8.09 as on November 7, 2026 at 8:46 am IST at the close of the market. Aspire Biopharma Holdings share today touched a day high of $7.99 and a low of $6.90.

What is the 52 week high and 52 week low for Aspire Biopharma Holdings share?

Aspire Biopharma Holdings share touched a 52 week high of $372.00 on November 10, 2025 and a 52 week low of $3.31 on May 8, 2026. Aspire Biopharma Holdings stock price today i.e. November 7, 2026 at 8:46 am IST is closed at $8.09,which is 97.83% down from its 52 week high and 144.48% up from its 52 week low.

What is Aspire Biopharma Holdings's market capitalisation today?

Aspire Biopharma Holdings market capitalisation is $0.00T as on November 7, 2026 at 8:46 am IST.

How to invest in Aspire Biopharma Holdings Stock (ASBP) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Aspire Biopharma Holdings on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Aspire Biopharma Holdings Stock (ASBP) from India?

Indian investors can start investing in Aspire Biopharma Holdings (ASBP) shares with as little as ₹93.91000366210938 or $1 (as of November 8, 2026 at 2:05 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹939.10 in Aspire Biopharma Holdings stock (as per the Rupee-Dollar exchange rate as on November 8, 2026 at 2:05 pm IST). Based on Aspire Biopharma Holdings share’s latest price of $8.09 as on November 7, 2026 at 8:46 am IST, you will get 1.2361 shares of Aspire Biopharma Holdings. Learn more about fractional shares .